Literature DB >> 15821890

Reduced type 1 and type 2 cytokines in antiviral memory T helper function among women coinfected with HIV and HCV.

Maria C Villacres1, Oana Literat, Marina Degiacomo, Wenbo Du, Corinna La Rosa, Don J Diamond, Andrea Kovacs.   

Abstract

Bias in cytokine responses has been proposed as a contributing mechanism to pathogenesis in persistent HIV or hepatitis C virus (HCV) infections. We investigated whether coinfection with HCV modifies the profile of antigen-specific cytokine secretion in women persistently infected with HIV compared to women with single HIV or HCV infection. The T helper response to HIV, HCV and cytomegalovirus (CMV) as a positive viral control was dominated by type 1 cytokines (interleukin- [IL] 2, interferon- [IFN] gamma and tumor necrosis factor- [TNF] alpha), with IFN-gamma as the most abundantly secreted. IL-4, IL-5 and IL-10 were low in healthy controls and patients. Robust CMV-specific responses contrasted with curtailed HCV-specific responses in HCV-infected women. The overall anti-viral profile was dominated by Th1 cytokines even in coinfected women but both type 1 and type 2 responses were reduced in HIV-infected women and more extensively in women with HCV/HIV coinfection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15821890      PMCID: PMC3127261          DOI: 10.1007/s10875-005-2819-x

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  45 in total

1.  Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging.

Authors:  M Clerici; N I Stocks; R A Zajac; R N Boswell; D R Lucey; C S Via; G M Shearer
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

2.  Sustained high frequencies of specific CD4 T cells restricted to a single persistent virus.

Authors:  Martina Sester; Urban Sester; Barbara Gärtner; Boris Kubuschok; Matthias Girndt; Andreas Meyerhans; Hans Köhler
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

3.  Inconsistent reconstitution of cytomegalovirus-specific cell-mediated immunity in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy.

Authors:  A Weinberg; D A Wohl; R J Barrett; C van der Horst
Journal:  J Infect Dis       Date:  2001-07-30       Impact factor: 5.226

4.  Immune activation and decreased tryptophan in patients with HIV-1 infection.

Authors:  D Fuchs; A Forsman; L Hagberg; M Larsson; G Norkrans; G Reibnegger; E R Werner; H Wachter
Journal:  J Interferon Res       Date:  1990-12

5.  Human immunodeficiency virus type 1-hepatitis C virus coinfection: intraindividual comparison of cellular immune responses against two persistent viruses.

Authors:  Georg M Lauer; Tam N Nguyen; Cheryl L Day; Gregory K Robbins; Theresa Flynn; Katherine McGowan; Eric S Rosenberg; Michaela Lucas; Paul Klenerman; Raymond T Chung; Bruce D Walker
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

6.  Early effects of HIV on CD4 lymphocytes in vivo.

Authors:  J V Giorgi; J L Fahey; D C Smith; L E Hultin; H L Cheng; R T Mitsuyasu; R Detels
Journal:  J Immunol       Date:  1987-06-01       Impact factor: 5.422

7.  Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins.

Authors:  T R Mosmann; H Cherwinski; M W Bond; M A Giedlin; R L Coffman
Journal:  J Immunol       Date:  1986-04-01       Impact factor: 5.422

8.  T cell apoptosis by kynurenines.

Authors:  Francesca Fallarino; Ursula Grohmann; Carmine Vacca; Ciriana Orabona; Antonio Spreca; Maria C Fioretti; Paolo Puccetti
Journal:  Adv Exp Med Biol       Date:  2003       Impact factor: 2.622

9.  Interferon-gamma response by peripheral blood mononuclear cells to hepatitis C virus core antigen is reduced in patients with liver fibrosis.

Authors:  Mark W Watson; Aleksandra Jaksic; Patricia Price; Wendy Cheng; Marian McInerney; Martyn A French; Scott Fisher; Silvia Lee; James P Flexman
Journal:  J Infect Dis       Date:  2003-11-04       Impact factor: 5.226

10.  Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs.

Authors:  F Miedema; A J Petit; F G Terpstra; J K Schattenkerk; F de Wolf; B J Al; M Roos; J M Lange; S A Danner; J Goudsmit
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

View more
  5 in total

1.  A T2 cytokine environment may not limit T1 responses in human immunodeficiency virus patients with a favourable response to antiretroviral therapy.

Authors:  Patricia Price; Niamh M Keane; Silvia Lee; Andrew F Y Lim; Elizabeth J McKinnon; Martyn A French
Journal:  Immunology       Date:  2006-06-22       Impact factor: 7.397

2.  Altered Peptide Ligands Impact the Diversity of Polyfunctional Phenotypes in T Cell Receptor Gene-Modified T Cells.

Authors:  Timothy T Spear; Yuan Wang; Thomas W Smith; Patricia E Simms; Elizabeth Garrett-Mayer; Lance M Hellman; Brian M Baker; Michael I Nishimura
Journal:  Mol Ther       Date:  2018-02-02       Impact factor: 11.454

3.  Evaluating the impact of hepatitis C virus (HCV) on highly active antiretroviral therapy-mediated immune responses in HCV/HIV-coinfected women: role of HCV on expression of primed/memory T cells.

Authors:  Lena Al-Harthi; John Voris; Wenbo Du; David Wright; Marek Nowicki; Toni Frederick; Alan Landay; Andrea Kovacs
Journal:  J Infect Dis       Date:  2006-03-17       Impact factor: 5.226

4.  Defective response to Toll-like receptor 3 and 4 ligands by activated monocytes in chronic hepatitis C virus infection.

Authors:  M C Villacres; O Literat; M DeGiacomo; W Du; T Frederick; A Kovacs
Journal:  J Viral Hepat       Date:  2008-02       Impact factor: 3.728

5.  Dynamic analysis of Th1/Th2 cytokine concentration during antiretroviral therapy of HIV-1/HCV co-infected patients.

Authors:  Wenzhen Kang; Yuan Li; Yan Zhuang; Ke Zhao; Dedong Huang; Yongtao Sun
Journal:  BMC Infect Dis       Date:  2012-04-25       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.